Patents by Inventor Rachael Terry

Rachael Terry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified immune-modulating particles
    Patent number: 11020424
    Abstract: The presently claimed invention relates to methods of reducing the duration or severity of an inflammatory immune response. In embodiments, the method comprises administering poly (lactic acid) (PLA) particles, poly (glycolic acid) (PGA) particles, poly (lactic-co-glycolic acid) (PLGA) particles, or combinations thereof; wherein said particles are modified to contain one or more carboxyl groups on the particle's surface. In embodiments, the particles do not comprise therapeutically active ingredients.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: June 1, 2021
    Assignee: onCour Pharma, Inc.
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King
  • MODIFIED IMMUNE-MODULATING PARTICLES
    Publication number: 20200338116
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated poly-styrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Application
    Filed: April 7, 2020
    Publication date: October 29, 2020
    Inventors: Daniel R. GETTS, Rachael TERRY, Nicholas KING
  • Modified Immune-Modulating Particles
    Publication number: 20200030369
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated poly-styrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Application
    Filed: October 16, 2019
    Publication date: January 30, 2020
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King
  • Modified immune-modulating particles
    Patent number: 10471093
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: November 12, 2019
    Assignee: Cour Pharmaceuticals Development Company.
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King
  • Modified Immune-Modulating Particles
    Publication number: 20190099443
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Application
    Filed: October 3, 2018
    Publication date: April 4, 2019
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King
  • MODIFIED IMMUNE-MODULATING PARTICLES
    Publication number: 20150174155
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 25, 2015
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King
  • MODIFIED IMMUNE-MODULATING PARTICLES
    Publication number: 20130323319
    Abstract: The current invention involves the surprising finding that when carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
    Type: Application
    Filed: November 14, 2011
    Publication date: December 5, 2013
    Applicant: GETTS CONSULTING AND PROJECT MANAGEMENT
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King